Medicine
Evidence-based Pharmaceutical Practice Responding for Novel Coronavirus Pneumonia Epidemic/ 中国药房
Zha Yi, Hao Guo, Shibo Qi, Tiantian Zhou, Rongsheng Zhao
2020China Pharmacy
tlooto Summary
Treatment progress of COVID-19, banned for use with lopinavir/ritonavir and adverse drug reaction and evidence of drug treatment mainly comes from in vitro cell test or currently progressing RCT, is obtained.
Abstract
Abstract is not available.
Citation format
YI, Zha, et al. Evidence-based pharmaceutical practice responding for novel coronavirus pneumonia epidemic/ 中国药房. China Pharmacy, 2020, 31: 527–531.